Covid Information

Information related to  COVID-19 

publications-layer

Official Memorandums

corona

Stop the Transmission, Crush the Pandemic

May 20 2021
covid
Covid-19

Reprioritizing Health R&D in context of COVID 19

Dec 10 2020
corona
Covid-19

COVID-19: Initiatives from the Office of the PSA

Oct 25 2020

Publications, Manuals/ Handbooks

Stop the Transmission, Crush the Pandemic

READ MORE

Home care tips for managing COVID-19

READ MORE

Manual on homemade protective covers for face and mouth

READ MORE
covid

Stop the Transmission, Crush the Pandemic

READ MORE
covid

Home care tips for managing COVID-19

READ MORE
covid

Manual on homemade protective covers for face and mouth

READ MORE
covid

Handbook for states/local bodies and communities to contain the spread of COVID-19, especially in densely populated areas

READ MORE
covid

Building Positive Mental Health in Nine Simple Steps: Effective habits for a healthy life

READ MORE
covid

Handbook for COVID-19 testing in Research Institutions

READ MORE

Dashboard on state-wise Covid-19 vaccination of citizens in India

Sequencing and analyses of SARS-CoV-2 variants in India

India’s Vaccine Task Force co-chaired by Principal Scientific Adviser, Prof. K. VijayRaghavan, and Dr. Vinod Paul, Member (Health), NITI Aayog, met in December 2020 as B.1.1.7 was detected a few months ago in September 2020. the variant SARS-CoV-2 VOC 202012/01 (Variant of Concern, the year 2020, month 12, variant 01 or B.1.1.7). The variant was characterized by 23 nucleotide substitutions and not phylogenetically related to the SARS-CoV-2 virus circulating in the United Kingdom at the time the variant was detected. On 30 December 2020, 31 other countries/territories/areas reported the variant (Source: World Health Organization). Also, were reported the B.1.351 variant of South Africa and P1, P2 of Brazil. The Vaccine Task Force, taking cognizance of the situation, reiterated the need for a common platform for harmonized protocols for virus surveillance, genome sequencing, and characterization in India.

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) was established to primarily build infrastructure across the country for genome sequencing, connect research outcomes to the clinical and epidemiological profile of patients and inform policymaking for effective control of the pandemic. INSACOG is a group of ten research laboratories the government put together to ramp up sequencing across India. INSACOG was formed with its center at the National Centre for Disease Control (NCDC) New Delhi, coordinated by MoHFW, CSIR, DBT, and ICMR for laboratory surveillance as well as epidemiological surveillance of B.1.1.7 strain of SARS-COV-2.

Q&A on Indian SARS-CoV-2 Genomics Consortium (INSACOG), Click here

Find out updates from INSACOG, Click here

 

topbutton

Back to Top